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Abstract 
The antidepressant effects of the polyherbal formulation (PF) (contain four extracts of medicinal 
plants namely: Nyctanthes arbortristis, Hippophae salcifolia, Ocimum tenuiflorum and Withania 
somnifera ) was examined by evaluating the extent of reduction of behavioural alterations and 
neurotransmitter in the rats stressed by forced swim test (FST). In the present study, compared 
with the model control group (FST), the altered behavioural parameters were attenuated 
significantly (P < 0.05) in the group treated with the PF (100,200 and 400 mg kg−1), comparable 
with the standard drug treated group, Sertraline (10mg kg−1). The PF and Sertraline 
significantly (P < 0.05) increased the level of the neurotransmitter such as serotonin, dopamine, 
acetylcholine and noradrenalin whereas decreased the level of monoamine oxidase along with 
oxidant in the brain of the stressed rats. PF and Sertraline were also involved in the reduced 
oxidant and generated antioxidant in the stressed rats. The results indicated that polyherbal 
formulation exhibited significant antidepressant activity, as indicated by its ability to decrease 
force swim stress, induced immobility time in rats as well as restoring the biogenic amines to 
normal level that were altered by the swim induced stress in whole rat brain. Therefore, PF can 
be a potential candidate for treatment of depression as well as a potent antidepressant. 
However, further studies are required to substantiate the same. 
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Introduction 
Depression is an etiologically heterogeneous 
group of chronic psychiatric illness with a high 
prevalence rate (21%) and the second leading 
cause of the loss of human disability-adjusted 
life year [1-4]. The prevalence rate of depression 
is 6-8 % in female and 3-5% in male [5]. 
Clinically characterized by a wide range of 
symptoms that reflect alternation in cognitive, 
psychomotor, biological, motivational, 
behavioral, emotional process and refers to 
either negative effect or absence of positive 
effects. The studies have suggested, depression 
also affects the quality of life of many people 
and has become a major cause of suicidal death 
[6-9]. 
Although, treatment of depression entirely 
depends on clinically available synthetic 
antidepressants (that based on serendipitous, 
act via monoamine neurotransmitters, such as 
serotonin and noradrenaline). Only certain 
portion of the patients show full remission in 
response to these antidepressants and other 
hand, associated with more side-effects and the 
chronic toxicity that affect almost every organ 
system. These available drugs have potential for 
adverse effects on cognition and behavior [10-
11]. To obtain better therapeutic benefits and 
minor adverse reactions, there is a pressing need 
for alternative antidepressant from natural 
source i.e., herbal remedies, used traditionally, 
now documented with safe profile [12-13]. 
Recently, it has been reported the use of 
polyherbal formulation exhibiting synergistic 
activity achieving maximum beneficial potency 
as compared to single herb [14-15].  
 The use of PF finds the way of curing 
depression. Ayurveda declared, more than a 
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few plants of this formulation, the so-called 
“medhya” plants, possess such antioxidant, 
antidepressant and anxiolytic properties. 
Nyctanthe sarbor-tristis, (N. arbor-tristis,) (Family 
Oleaceae) is an herb that has been used in India 
for centuries as an anti-inflammatory [16], 
analgesic, antipyretic, ulcerogenic activities [17-
20], immunostimulant activity and anxiolytic 
activity. Hippophae salcifolia (H. salcifolia) 
(Seabuckthorn) are deciduous shrubs in the 
family Elaeagnaceae that traditionally used as 
anti-stress and improve, enhance physical 
endurance, mental function alone but there are 
limited published data in related to centrals 
nervous system disorders [19-21]. It has also 
shown anti-oxidant, immuno-modulatory, anti-
inflammatory and homocysteine lowering 
effects because it is a rich source of flavonoids, 
vitamins, proteins, amino acids, folic acid, 
phytosterol, alpha-tocopherol and phenolic 
compounds [21]. 
Ocimum tenuiflorum (O.tenuiflorum) (Family 
Lamiaceae), has wild growth and available 
throughout the Eastern World Tropics and 
contains eugenol, oleanolic acid, ursolic acid, 
rosmarinic acid, etc. It has a vast number of 
therapeutic applications such as cardiopathy, 
haemopathy, leucoderma, asthma, bronchitis, 
catarrhal fever, otalgia, hepatopathy, vomiting, 
lumbago, hiccups, ophthalmia, gastropathy, 
genitourinary disorders, ringworm, verminosis 
and skin diseases etc due to presence of 
abundance of naturally occurring polyphenols 
in Ayurveda, Greek, Roman, Siddha and Unani.  
These polyphenols possess potential effects of 
neuroprotection. Due to high concentration of 
eugenol act as COX-2 inhibitor and analgesic 
effect [22-28]. 
Withania somnifera (W. somnifera) is known as 
Ashwagandha, an Ayurvedic formulation 
mentioned in traditional medicine system, used 
as a mild sedative, aphrodisiac rejuvenative and 
possess a very good effect in all psychological 
disorders. The roots of W. somnifera consist very 
active compounds known as withanolides, is a 
strong potent psycho neuro pharmacologically 
active molecules and is subjected for 
antidepressant activity. Various studies have 
shown it is effective in the treatment of chronic 
fatigue, nervous exhaustion, and memory loss 
and neurodegenerative disorders and there are 
limited published data [29-30].  Even though PF 
has antidepressant potential, there is no 
sufficient evidence for its effects in animal 
models of depression. According to Ayurveda-
“Sarangdhar Samhita” dated centuries ago in 
1300 AD has highlighted the concept of 
polyherbalism in this ancient medicinal system 
to achieve additional therapeutic effectiveness 
[31].  
Recent studies have shown that different herbal 
active bio molecules of PF, possess potential 
effects of neuroprotection [32-35]. So far, no 
study has appeared about the protective effects 
of this polyherbal formulation on depression 
induced by forced swim stress. Considering 
substantial neuroprotective properties of PF, we 
sought to investigate whether PF could improve 
level of neurotransmitter induced by Forced 
swim stress in rats; and to explore the 
underlying mechanisms for the same. 
Materials and Methods 
Animals  
Albino Wistar rats (with 2 months of age and 
both genders), weighing 150 to 200g were taken 
from the central animal house of Adesh 
University, Bathinda, Punjab. All animals were 
kept in polypropylene cages with paddy husk as 
bedding. The rats were housed in groups of 6 
animals per cage and acclimatized to a colony 
room with a controlled ambient temperature 23 
± 2ºC, relative humidity of 50–70% and a 12-
hour natural light/dark cycle. The animals had 
free access to pelleted feed of standard 
composition containing all macro and micro 
nutrients and purified water ad libitum and 
were acclimated for 7 days prior to the 
consequent studies. The animals were examined 
at regular intervals by a trained personal for any 
behavioural abnormalities and behavioural 
studies were carried out during the light phase 
(10.00 am–1.00 pm). The animals were used only 
once for each experiment. The experiments were 
performed after approval of the protocol by the 
Ethics Committee of the Adesh University, 
Bathinda Punjab with reference number; 
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AIMSR/MC/Estt/07/2009/718 & dated 16-07-
2009. 
Collection of polyherbal hydro-
alcoholic extract  
 The hydro-alcoholic extracts of four plants-
Nyctanthe sarbortristis (75mg), Occimum 
tenniflorum (50mg), Hippophe salcifolia (40mg) 
and Withania somnifera (35mg) in the 
combination as a polyherbal formulation (PF). 
The source of hydro-alcoholic extract of four 
plants from Bajinath Pharmaceutical Pvt. Ltd., 
Paprola Himachal Pradesh. PF was freshly 
suspended in distilled water and administered 
per oral (p.o.) in a constant volume of 10 ml/kg. 
The dose of extracts per rat was calculated with 
the values obtained in gravimetric assay and 
estimated at 2000g/kg/day. Different doses of 
test drug (100,200,400 mg/kg/day) were 
administered orally by using oral gavage in rats, 
40-45 min before the behavioural tests. 
Sertraline HCL was used as the reference 
standard drug for evaluating antidepressant 
activity. Sertraline HCL suspension was 
prepared using saline. 
Drug and analytical chemical 
Sertraline hydrochloride, (1S,4S)-4-(3,4-
dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-
naphthalen-1-amine selective reuptake inhibitor 
antidepressant, was gifted from Sun 
pharmaceutical company Baddi, Himachal 
Pradesh and used as positive control for 
antidepressant action. All other reagents and 
solvents were of analytical grade. Polyherbal 
formulation was dissolved in 0.5% Carboxyl 
Methyl Cellulose (CMC) with 1% Tween 80 
(solubility enhancer). The dissolution of the 
extract wasfreshly done from the powder 
immediately before its administration. A control 
group received equal volume of distilled water. 
Experimental design  
There were six groups in this present study: 
Group I: 0.5% Carboxyl Methyl cellulose (CMC) 
plus unstressed, Group II: Water plus Stressed, 
Groups III: Sertraline hydrochloride (10 
mg·kg−1, i.p.) plus stressed and the at 30 min 
before exposure to stress), Group VI and IV: PF 
(polyherbal formulation) plus stressed (100, 200 
and 400 mg·kg−1 p.o., respectively) (treatment at 
60 min before exposure to stress). PF and 
sertraline hydrochloride were each given orally 
by gavage, 60min before each stressor once 
every day for 7th, 14th and 28 days. 
 Measurement of immobility period by 
forced swim test (FST) 
The forced swim test was performed according 
to the method described by Porsolt [36] with 
slight modifications [37].This test consisted of 
two parts, an initial training period of 15 min 
and an actual test for 5 min after 24 h. The rats 
were individually forced to swim inside vertical 
plastic jar (26 cm × 12 cm × 26 cm) containing 
water to a height of 15 cm at 25 ± 2 °C for a 5  min 
session every day for 7 days. When they were 
placed in the glass jar for the first time the rats 
were initially highly active, vigorously 
swimming in circles, and trying to climb the 
wall or diving to the bottom. After 3–4 min, their 
activity began to fall down and immobility 
increased. After 5–6 min, immobility reached a 
raised ground where the rat remained immobile 
more than 70% of the time. After 15 min in the 
water, the rats were removed, wiped with dry 
cloth and allowed to dry before being returned 
to their cages. The plastic jar was emptied and 
washed thoroughly after testing for each rat. 
The rats were again placed in the jar 24 h later 
after initial administration of the drug and 
extracts and their activity was recorded within 5 
min. The duration of immobility was measured 
using a stop watch. An animal was judged to be 
immobile whenever it remained floating 
passively in the water in a slightly hooked but 
vertical position and sometime horizontal 
position, with no additional activity other than 
that necessary to keep its head above water [36-
37].  
Behavioral assessment 
Numerous other behavioral parameters were 
assessed in the rats on 7th, 14th and 28th days 
after forced swim stress test. All the animals 
were subjected for other behavioral analysis 
such as anxiety and memory. The mirror 
chamber test was used as a measure of anxiety 
[38] while for cognitive behavior the elevated 
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plus maze test was used, developed by Kulkarni 
[39]. 
Biochemical assay 
Biochemical tests for neurotrans-
mitter and other biomarker in all rats 
On Day 7th, 14th and 28th, after mentioned 
behavioral analyses, the rats were immediately 
sacrificed by cervical dislocation. The brains 
were immediately removed and 10 % (W/V) 
tissue homogenate was prepared in 0.1 mol·L−1 
phosphate buffer (pH 7.4). The homogenates 
were centrifuged for 15-20 min at 10000 g and 
the supernatants were used for analyses of 
serotonin, melatonin, monoamine oxidase, 
noradrenalin, acetylcholine, lipid peroxidation 
and glutathione levels. The serotonin and 
melatonin were estimated according to the 
methods described by Snyder et al [40] and 
Ozaki et al [41] respectively in the brain tissue. 
The level of monoamine oxidase in the rat brain 
tissue was measured by using the procedure of 
Xu et al. [42] with a minor modification and 
noradrenalin and acetylcholine, estimated by 
high performance liquid chromatography with 
fluorescence detection (HPLTC) method 
[28].Lipid peroxidation was assayed byof the 
presence malondialdehyde, a biomarker in form 
of thiobarbituric acid-reactive substances by the 
method of Wills et al [43] whereas glutathione in 
brain was analyzed according to the method 
described by Ellman et al [44]. 
Data analysis 
Behavior assay was analyzed statistically using 
Graph pad prism a one-way analysis of variance 
(ANOVA), followed by Turkey’s test. The 
results were expressed as the mean ± standard 
error of the mean (SEM.). Differences with p 
values < 0.05 were considered statistically 
significant. For biochemical assays, one-way 
ANOVA was applied on the percentage values 
of each group calculated with respect to positive 
and negative control group. The values were 
expressed as mean ± SEM. 
Results  
Body weights on 7th, 14th, and 28th 
days  
At the beginning of the experiment, there were 
no significant differences in body weight among 
the six groups (P> 0.05), with the values (mean 
± SD) being 104± 2.45, 101.71 ± 6.2, 103.52 ± 1.15, 
105.59 ± 12.45, 107.98 ± 15.6, 104.9±7.78 and for 
groups 1–6 respectively. The body weights at 
the 7th, 14th and 28th days of the treatments 
were also not significantly different among the 
groups (P > 0.05); the values of 7th days were 
106± 3.2, 105.51 ± 7.45, 104.92 ± 2.15, 108.47 ± 
13.1, 109.91 ±6.12,105.9±5.78 and 14 days were 
133.3 ±15.57, 129.35 ±28.62, 123.95 ± 15.43, 131.09 
±28.78, 135.64 ±24.16 and 125 ±31.22 whereas on  
the  28days the value of body weight were 135.80 
±12.6, 131.33 ±17.98, 133.19 ±12.2, 135.9 ±13.04, 
139.19 ±44, and 133.33± 5.2, 1–6 respectively. 
Therefore, the results suggested that polyherbal 
formulation or Sertraline didn’t show any 
toxicity effect in treatment group.  
Effects of polyherbal formulation (PF) 
on the immobility time in the forced 
swim (FST) test and its anti-anxiety- 
After treatment with the PF for 7,14 and 28 
consecutive days, there was a significant 
reduction in immobility time in the forced swim 
test, in a dose-dependent manner, compared 
with the experimental control (stressed) rats (P 
< 0.05, Figure 1). The reduction in immobility 
after the treatment with the PF demonstrated its 
antidepressant-like potentials, since decreased 
swimming performance would increase the 
immobility time in the forced swim test. 
Sertraline was used as the standard drug for 
antidepressant activity on the forced swim test. 
As presented in Figure 1, Sertraline caused a 
significant reduction in immobility time. Effect 
of test drug on biochemical parameters. 
PF were also exerted anti-anxiety like effect 
because it decreased time latency to enter in 
mirror chamber and also increased number of 
entries in stressed rat. Figure 2 a to c showed the 
standard drug, Sertraline, was more effective 
than the PF (P < 0.05, Figure. 2 a, b and c). 
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Figure. 1: Effect of PF on the immobility time in 
the stressed rats. Sertraline was used as a 
positive control. 
Figure.2: Effect of the PF on Anxiety (a) latency 
of entries (s) (b) Time spent and (c) Number of 
entries  
Effect of polyherbal formulation (PF) 
treatment on biochemical parameter: 
Brain serotonin levels 
Serotonin levels were estimated in the whole 
brain content of rats. FST model exhibited 
significantly lower value of serotonin levels, 
expressed as percentage values with respect to 
the control group. More than a 40% decrease in 
serotonin levels was observed due to depression 
induced model group. PF treatments showed 
significantly increased brain serotonin levels in 
model group (Figure 3). Also, Sertraline was 
increased the level of serotoninin the brain of 
stressed rats as compared to model group.  
 
Figure. 3: Effect of the PF on level of serotonin 
in stressed rat’s brain 
MAO enzyme activity 
FST model rats resulted in a significant increase 
in total MAO enzymatic activity in the brain as 
compared to the Sertraline and test drug 
treatment group. The effects of PF and Sertraline 
on the MAO activities in the rat brain are shown 
in fig 4. Test drug at doses of 100, 200 and 400 
mg/kg suppressed the brain monoamine 
oxidase activities. The data represented 25. 2% 
increases in total MAO activities in the whole 
brain content of FST rats with respect to 
Sertraline treated rats respectively. PF treatment 
significantly reduced the level of total MAO 
enzyme activities in the brain within 28 days at 
400mg/kg. Similar results were observed for the 
Sertraline treatment.  
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Figure. 4: Effect of the PF on level of MAO in 
stressed rat’s brain 
Noradrenalin  
Figure. 5: Effect of the PF on level of 
noradernalin in stressed rat’s brain 
Noradrenalin levels were estimated in the 
whole brain content of rats. Model group 
exhibited significantly lower value of 
noradrenalin levels compared to the control 
group. PF treatments showed significantly 
increased brain noradrenalin levels in treated 
group (Figure 6).  
Figure. 6: Effect of the PF on level of 
acetylcholine in stressed rat’s brain 
Also, Sertraline showed recovered brain 
noradrenalin levels increase as compared to 
model group. At the dose, 400mg/kg 
significantly increased the level of noradrenalin 
in the brain of depressive rats and this 
concentration is effective doses for recovery of 
noradrenalin in the brain.  
Acetylcholine  
PF gradually increased the level of acetylcholine 
in the brain of depressive rats while 200mg/kg 
concentration significantly increased level of 
acetylcholine. These level are lower as 
compared to standard drug figure 6.  
Lipid peroxidation and glutathione   
PF gradually increased the level of 
malondialdehyde in the brain of depressive rats 
while these level are lower as compared to 
standard drug figure 7. Simultaneously; we 
observed the glutathione level in brain of 
stressed rats decreases.  
 
Figure. 7: Effect of the PF on level of reduced 
glutathione in stressed rat’s brain 
 
Figure. 8: Effect of the PF on level of lipid 
peroxidation biomarker in stressed rat’s brain 
Discussion  
After screening of plants having role on central 
nervous system four plants namely Nyctanthes 
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arbortristis (parijata), Hippophae salicifolia 
(amlavetas), Occimum tennuiflorum (van tulsi) 
and Withania somnifera were selected on the 
basis of their biological activity. Hydro-alcohol 
extract of four medicinal plants(Nyctanthe 
sarbortristis; Hippophae salcifolia ;Ocimum 
tenuiflorum ; Withania somnifera) has been 
reported to possess potent different activity-
anti-inflammatory,anti-oxidant,COX-2 inhibitor 
and analgesic effect and chronic fatigue, 
nervous exhaustion, memory loss, 
neurodegenerative disorders etc, respectively 
due to presence of major effective constituents 
such as nyctanthic, lupeol, ascorbic acid, 
flavonoids, folic acid, oleanolic acid, ursolic 
acid, rosmarinic eugenol and 35 withanolides 
with 12 alkaloids and several sitoindosides [16-
30]. Therefore, all the four plants have shown 
their action on various targets involved with 
depression like monoamine content, pro-
inflammatory markers, behavioral pattern etc 
and the selected four plants were taken and after 
determination of bio-activity the plants were 
taken for standardization and quality control 
studies and to develop a polyherbal formulation 
beneficial in the management of depression of 
varying etiology. We hypothesized PF could be 
effective in the management of diseases caused 
by imbalance of monoamines or 
neurotransmitter, inflammatory, injury fatigue 
and oxidative stress. To test the hypothesis, we 
evaluated the effects of the nyctanthic, oleanolic, 
eugenol, withanolides, flavonoids and folic acid 
rich hydro-alcoholic extract on behavioral 
alterations in stressed rats. 
The present study can be summarized by 
following finding: 1. the force swim stress 
procedure caused depressive-like behavior in 
treatment rats, as observed by different assays 
such as mirror chamber test and elevated plus 
maze test; 2. significant reduction in depressive-
like behaviors was evident in the stressed rats 
treated with PF and Sertraline (positive control);  
3. forced swim test procedures imbalance the 
neurotransmitter and induced inflammatory 
injury along with oxidative damage by 
increasing lipid peroxidation in the treated rats  
and  4. PF and Sertraline treatments exerted 
protective effects against forced swim stress and 
increase the level of neurotransmitter and 
decrease the glutathione in the rat brain. 
Numerous studies have been indicated that 
stressful life events and chronic stresses are risk 
factors for several neurodegenerative diseases 
including depression because it is capable to 
altering physiological homeostasis of body and 
imbalance the neurotransmitter in brain [45-47]. 
Depression is an incapacitating psychiatric 
ailment which is characterized by a pervasive 
low mood, loss of interest in usual activities, 
diminished ability to experience pleasure 
(anhedonia), withdrawal of interest, feelings of 
worthlessness, and suicidal tendencies [1-9]. 
Most commonly, FST is employed behavioral 
model of depression and used to evaluate the 
antidepressants drug [48]. The poly herbal 
formulation as found to be safe in as no 
mortality was observed following treatment. 
The immobility exhibited by test animals in 
these models is an indicative of a behavioral 
despairness which reflects a state depressive 
state. Group IV to VI showed a significant 
decrease in their immobility time showed a 
moderately significant decrease in immobility 
time compared to control and model group. 
Sertraline showed extremely significant 
reduction in the immobility time. 
On the other hand, anxiety is a part of which is 
psychological and behavioral state induced in 
animals and humans by stress-like conditions 
and characterized by fear and annoyance. 
Serotonin level is decreases in the anxiety 
condition [38]. In our present study, anxiety 
evaluated by mirror chamber test [39] and we 
found the PF and Sertraline both significantly 
increase the time spent, number of entries and 
decreases latency entries (Figure 2)and increase 
the serotonin in the stressed rats. 
The elevated plus maze test is used to evaluate 
cognitive behavior and memory performance 
[49]. According to the report [49,50], the rodents 
are like to live in enclosed and dark area. Our 
data of this behavior assays showed that PF, 
changes in both open arm entries and time spent 
in open arms significantly (P < 0.05) and 
Sertraline is also increased the open arm entries 
and time spent in open arm (P < 0.05) whereas 
model group showed significant reduction in 
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open arm entries and the time spent in open arm 
(P < 0.05). Therefore, this study showed that PF 
and Sertraline, both promote glucocorticoid 
production and release in the adrenal cortex 
[50]. 
As we know Sertraline acts by the selective 
serotonin reuptake inhibitor (SSRI) pathway 
and has been used as a standard drug in 
majority studies. The beneficial effect of 
Sertraline in the FST model seems to be due to 
increased availability of these neurotransmitters 
nor epinephrine (NE), acetylcholine, melatonin 
and serotonin (5HT) at the post synaptic site 
following reuptake inhibition due presence of 
potential phytocontituents and so forth 
produces anti-depressive actions. On the other 
hand, depression is a multifaceted mental illness 
resulting from alterations in central 
serotonergic, melatonin, noradrenergic, and 
system along with MAO activity. The 
monoaminergic hypothesis of depression 
postulates that the major neurochemicals 
process in depression, is the impairment of 
monoaminergic neurotransmission and the 
concomitant decrease in extracellular 
concentration of noradrenaline and serotonin 
[36,44,51]. Most of the prescribed 
antidepressants inhibit serotonin or 
noradrenaline reuptake and mono 
amineoxidase inhibitors act by increasing the 
synaptic availability of these neurotransmitters 
[36,44]. The dopaminergic system is also an 
important target implicated in the regulation of 
mood disorders, as preclinical and clinical 
studies have indicated a diminished dopamine 
turnover in depression [36]. As a result, 
depressive disorders are commonly due to 
imbalance in neurotransmission and it bring this 
imbalance back to balance consists in inhibiting 
the uptake of neurotransmitters into the 
neurons, thus neurotransmitters levels 
increasing in the brain and shown to improve 
the clinical symptoms of depression. Among 
them are chemical entities like tricyclic 
antidepressants or herbal extracts as 
demonstrated here and by many others [34-38]. 
Consequently, it was thought to be worthwhile 
to estimate all the five neurotransmitters in 
brain of rats depressed by forced swimming and 
tail suspension test. Model group have shown 
decreased levels of 5-HT, melatonin, NA, and 
acetylcholine with increases the activity of 
MAO, indicating a state of depression while 
treated animals exhibited increased levels of 
these biogenic amines and low level of MAO 
activity. In that test drug 400 mg/kg produced a 
significant increase in 5-HT, melatonin, NA, and 
acetylcholine levels at 28th days. This effect was 
comparable to the standards used.  
Various studied have been shown the oxidative 
stress has been associated in the 
pathophysiology of many neurological 
disorders and caused anxiety and stress lead to 
depression [52-53] due to reactive oxidative 
stress (ROS) as like hydroxyl radicals, 
superoxide anion, hydrogen peroxide and nitric 
oxide. These are involved in the oxidative 
damage to lipids, neuronal inflammation and 
reduced intracellular antioxidant altered the 
membrane function and signaling process in the 
brain [54-55]. 
In the present study, forced swim test caused the 
stress, lead to oxidative damage in stressed rats 
and decreases the glutathione, represents a main 
cellular non-protein and antioxidant that redox 
regulator in protecting oxygen species. It also 
regulate lipid peroxidation and also decrease in 
catalase activity. Studies had been reported that 
catalase and lipid peroxidation, are lined to 
depressant-like behavior. In the present studies 
we found that malondialdehyde (biomarker of 
lipid peroxidation) is higher in the FST model 
whereas its level was reduced in PF and 
Sertraline treated rats because the both drugs 
induced the more synthesis of reduced 
glutathione, involved in diminished catalase 
activity [56-57]. Studies have been shown these 
catalase activity increases lipid peroxidation 
through metals transition reaction resulting 
generate the radical hydroxyl, which cause 
oxidative injury, inflammation and neuronal 
damage. Therefore, PF and standard drug 
increased the level of glutathione in the stressed 
rats and protecting the neuron from oxidative 
stress and damage. As a result, all of these plants 
are classified in Ayurveda as rasayanas which 
are apparent to promote mental health, improve 
Nepal Journal of Biotechnology. Dec .  2019  Vol. 7, No. 1: 63-73                    Kumari et al. 2019 
 
©NJB, Biotechnology Society of Nepal  71 Nepjol.info/index.php/njb. 
 
 
immunity and enhance long life of individuals 
[58-59]. 
Further studies will reveal the mechanisms by 
which test drug synergistically enhances the 
antidepressant activity especially on the 
serotonergic system. Taken together, our data 
proved that the anti-depressive therapeutic 
effects of test drug are possible with 400mg/kg 
doses, when it compared with standard. This 
might be due to different mechanisms by which 
four extracts act on the neurotransmitter system. 
Conclusion 
In the present study, forced swim stress (FST) 
was used to developed depressive like behavior 
in rats for 7, 14 and 28 days. It was an increased 
immobility time, anxiety and impaired 
cognitive behavior in the experiment rats 
(stressed). It was also imbalanced biochemical in 
FST model (stressed rats) through the reduction 
of different neurotransmitter that altered 
behavioral parameters and it were attenuated 
significantly by administration of the polyherbal 
formulation (PF) comparable to Sertraline. Both 
drugs were capable to reduce the oxidative 
stress and decreases the level of reactive 
oxidative species through increased the level of 
antioxidant in the brain. It was protected the 
neuron from the neuronal damage and 
improved the cognitive behavior. However, PF, 
centrally exerts an antidepressant-like effect in 
the FST by a mechanism involving inhibition of 
serotonin reuptake, inhibition of MAO activity 
and evaluated the level of acetylcholine, 
melatonin and noradrenaline in the brain. Given 
that these targets have been increasingly 
reported to be involved in the pathophysiology 
of depression and on the antidepressant 
efficacy. Thus, poly herbal extract possesses 
antidepressant action demonstrated by 
modulation of serotonergic pathway, MAO 
receptors, acetylcholine, noradrenalin and 
melatonin in rats. 
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